Volitionrx (VNRX) Return on Equity (2019 - 2025)
Volitionrx's Return on Equity history spans 9 years, with the latest figure at 0.15% for Q4 2025.
- For Q4 2025, Return on Equity fell 17.0% year-over-year to 0.15%; the TTM value through Dec 2025 reached 0.15%, down 17.0%, while the annual FY2025 figure was 0.0%, 1.0% up from the prior year.
- Return on Equity reached 0.15% in Q4 2025 per VNRX's latest filing, up from 0.15% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 6.21% in Q4 2023 to a low of 23.88% in Q3 2023.
- Average Return on Equity over 5 years is 1.42%, with a median of 0.12% recorded in 2025.
- Peak YoY movement for Return on Equity: plummeted -2397bps in 2023, then skyrocketed 2463bps in 2024.
- A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then crashed by -25607bps to 2.3% in 2022, then surged by 370bps to 6.21% in 2023, then tumbled by -95bps to 0.32% in 2024, then plummeted by -53bps to 0.15% in 2025.
- Per Business Quant, the three most recent readings for VNRX's Return on Equity are 0.15% (Q4 2025), 0.15% (Q3 2025), and 0.16% (Q2 2025).